R1 RCM INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.36 USD | +0.37% |
|
+0.33% | -47.69% |
| May. 14 | Deutsche Bank Adjusts R1 RCM Price Target to $14 From $15, Maintains Hold Rating | MT |
| May. 08 | Health Care Slips as Defensive Investors Rotate to Utilities - Health Care Roundup | DJ |
Presentation Operator MessageOperator (Operator)Good morning, and welcome to the R1 RCM Inc. A...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
R1 RCM Inc. is a provider of technology-driven solutions that transform the financial performance and patient experience for health systems, hospitals, and physician groups. The Companyâs scalable operating models seamlessly complement a healthcare organizationâs infrastructure, driving sustainable improvements to net patient revenue and cash flows while reducing operating costs and enhancing the patient experience. The Company delivers solutions to customers through technology, intellectual property (IP), global scale, and operational excellence. Its Intelligent Automation modernizes processes, removes friction, and simplifies revenue cycle management (RCM). Its use of artificial intelligence (AI) in its platform depends on the availability and pricing of equipment and technical infrastructure from third parties, including Microsoft Azure. It serves over 3,700 hospitals, including 93 of the top 100 health systems, and over 30,000 physicians.
Calendar
2024-05-22
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
12.31
USD
Average target price
16.79
USD
Spread / Average Target
+36.36%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +18.87% | 84.52B | |
| -27.29% | 72.21B | |
| +4.65% | 27.74B | |
| -7.77% | 17.97B | |
| -0.46% | 17.46B | |
| +4.51% | 15.82B | |
| +8.76% | 13.55B | |
| +6.59% | 13.31B | |
| +69.67% | 12.5B |
- Stock Market
- Equities
- RCM Stock
- RCM Stock
- News R1 RCM Inc.
- Transcript : R1 RCM Inc. - Shareholder/Analyst Call